SMTL ID : 8i5x.1

Structure of human Nav1.7 in complex with Vinpocetine

Coordinates
PDB Format
Method
ELECTRON MICROSCOPY
Oligo State
hetero-1-1-1-mer
Ligands
3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x P5S: O-[(R)-{[(2R)-2,3-bis(octadecanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine(Non-covalent)
5 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
1 x 9Z9: (3beta,14beta,17beta,25R)-3-[4-methoxy-3-(methoxymethyl)butoxy]spirost-5-en(Non-covalent)
1 x T7F: Vinpocetine(Non-covalent)
11 x LPE: 1-O-OCTADECYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
5 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Wu, Q. et al., Structural mapping of Na v 1.7 antagonists. Nat Commun (2023)
Release Date
2023-06-14
Peptides
Sodium channel protein type 9 subunit alpha: A
Sodium channel subunit beta-1: B
Sodium channel subunit beta-2: C
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
Membrane
We predict this structure to be a membrane protein.

Sodium channel protein type 9 subunit alpha

Sodium channel subunit beta-1

Sodium channel subunit beta-2

Related Entries With Identical Sequence

6agf.1 | 6j8g.1 | 6j8h.1 | 6j8i.1 | 6j8j.1 | 7w77.1 | 7w7f.1 | 7w9k.1 | 7w9l.1 | 7w9m.1 | 7w9p.1 | 7w9t.1 | 7xm9.1 | 7xmf.1 | 7xmg.1 | 7xve.1 | 7xvf.1 | 8fhd.1 | 8g1a.1 | 8gz1.1 | 8gz2.1 | 8i5b.1 | 8i5g.1 | 8i5y.1 | 8j4f.1 | 8s9b.1 | 8s9c.1 | 8thg.1 | 8thh.1